0
个在招岗位
- 公司介绍
简介
格兰泰制药（中国）有限公司成立于1997年1月，是专业从事处方药生产、销售、开发的制药公司，是德国格兰泰集团在亚洲投资的一家全资子公司。
公司拥有符合GMP标准的、当今世界上至为先进的药品制剂技术和生产设备，按照国际标准进行管理和质量控制。
公司总部设在上海市；生产基地位于广东省中山市国家健康科技产业基地内；注册部设在北京市。
格兰泰集团是德国最大的抗生素和镇痛药研究和生产企业之一，拥有最现代化的研究所和生产厂，具有独立完备的新药开发能力。
格兰泰的药品研究开发范围主要包括：镇痛药、抗生素、激素、治疗心血管疾病的基因工程药物、神经疾病药物等。
公司的企业文化包括以下五个方面：
- 格兰泰集团的员工都有着强烈的自我责任感，我们细心准备，勇于探索，始终同公司一起共同发展；
- 我们相互信任和紧密合作，善于接纳不同的文化；
- 在“止痛”和“传染病处理”领域，格兰泰正不断提升其核心竞争力；
- 我们和其它研究机构以及公司合作的经验和意愿是我们成长战略的基石；
- 我们目前和未来提供的药品，必须满足质量、效率、安全和环保的高标准，并最终达到改善人类身体健康和生活质量的目标。
Grünenthal is an independent, family-owned, research-based pharmaceutical company based in Aachen operating internationally.
In 1948 Grünenthal was the first German company to manufacture and market penicillin. Today analgesics are our main competence.
Beside this Grünenthal is active in the marketing of oral contraceptives and the treatment of respiratory tract diseases.
The treatment of serious medical conditions with pharmaceutical products is one of the pillars of modern medical practice.
It is the goal of Grünenthal to help the medical profession improve treatment by providing drugs that satisfy unmet medical
needs.
The company focusses on the research and development of new drugs in the treatment of pain, and early successes from the Grünenthal
research include tramadol, currently world-wide the most prescribed weak opioid for the treatment of moderate to severe pain.
research at Grünenthal is directed at further developing its products already on the market and bringing to market new products
that are the fruit of its continued research effort over the past decade. The most recent examples of these are Transtec®,,,,,,,
and Zaldiar®,,,,,,,, two innovative pain treatments that are experiencing high levels of acceptance and market success.